Alpha-sarcoglycanopathy previously misdiagnosed as Duchenne muscular dystrophy: Implications for current diagnostics and patient care

European Journal of Pediatrics

Volumn 160, Issue 7, 2001, Pages 452-453

  Schara, Ulrike ^a   Gencik, Martin ^a   Mortier, Johannes ^b   Langen, Margarete ^a   Gencikova, Alexandra ^a   Epplen, Jörg Thomas ^a   Mortier, Wilhelm ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SARCOGLYCAN; SARCOGLYCAN; UNCLASSIFIED DRUG;

ADULT; ALPHA SARCOGLYCANOPATHY; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE MUTATION; GENOTYPE; HUMAN; IMMUNOHISTOLOGY; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; WESTERN BLOTTING;

ADOLESCENT; BLOTTING, WESTERN; CYTOSKELETAL PROTEINS; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; GLYCOGEN STORAGE DISEASE TYPE VII; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; SARCOGLYCANS;

EID: 0034917189     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310100744     Document Type: Article

References (9)

1. Optimized protein diagnosis in the autosomal recessive limb-girdle muscular dystrophies
2. Homozygous α-sarcoglycan mutation in two siblings: One asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient
3. Limb-girdle muscular dystrophies
4. Making sense of the limb-girdle muscular dystrophies
5. Current practice. Steroids in muscular dystrophy: Where do we stand?
6. Progressive muskeldystrophien
7. Mutation of dystrophin gene and cardiomyopathy
8. Langzeit-cortisontherapie bei duchenne-muskeldystrophie (DMD). Positive versus negative effekte